Prelude Therapeutics Incorporated (PRLD)
NASDAQ: PRLD · Real-Time Price · USD
2.840
-0.100 (-3.40%)
At close: Dec 30, 2025, 4:00 PM EST
2.784
-0.056 (-1.96%)
After-hours: Dec 30, 2025, 7:48 PM EST
Prelude Therapeutics Market Cap
Prelude Therapeutics has a market cap or net worth of $234.01 million as of December 30, 2025. Its market cap has increased by 248.45% in one year.
Market Cap
234.01M
Enterprise Value
196.91M
1-Year Change
248.45%
Ranking
Category
Stock Price
$2.84
Market Cap Chart
Since the IPO on September 25, 2020, Prelude Therapeutics's market cap has decreased from $806.64M to $234.01M, a decrease of -70.99%. That is a compound annual growth rate of -20.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 30, 2025 | 234.01M | 141.92% |
| Dec 31, 2024 | 96.73M | -70.04% |
| Dec 29, 2023 | 322.85M | 12.32% |
| Dec 30, 2022 | 287.43M | -50.22% |
| Dec 31, 2021 | 577.35M | -80.97% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 966.79B |
| Johnson & Johnson | 498.51B |
| AbbVie | 406.04B |
| UnitedHealth Group | 300.88B |
| AstraZeneca | 287.28B |
| Novartis AG | 266.00B |
| Merck & Co. | 263.24B |
| Novo Nordisk | 227.63B |